| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | actin filament binding | TPM2 MYH3 MYH8 MYH9 SHROOM3 NRAP NEBL MYO6 CFL1 CFL2 MYO1H SPTA1 NEB LRPPRC CTTN CNN3 | 2.80e-10 | 227 | 181 | 16 | GO:0051015 |
| GeneOntologyMolecularFunction | cyclosporin A binding | 1.36e-09 | 24 | 181 | 7 | GO:0016018 | |
| GeneOntologyMolecularFunction | actin binding | TPM2 MYH3 MYH8 MYH9 SHROOM3 NRAP NEBL MYO6 CFL1 CFL2 MYO1H INPPL1 SPTA1 GBP3 NEB LRPPRC CTTN CNN3 MYBPC1 | 7.87e-08 | 479 | 181 | 19 | GO:0003779 |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 3.22e-07 | 50 | 181 | 7 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 4.85e-07 | 53 | 181 | 7 | GO:0016859 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TPM2 MYH3 MYH8 MYH9 SHROOM3 NRAP KIF27 NEBL MYO6 CFL1 CFL2 MYO1H INPPL1 SPTA1 EML6 GBP3 TOGARAM1 SYBU NEB CEP350 RMDN3 LRPPRC LMO7 TTLL2 CTTN USH2A CNN3 MYBPC1 | 6.93e-07 | 1099 | 181 | 28 | GO:0008092 |
| GeneOntologyMolecularFunction | structural constituent of muscle | 2.36e-06 | 43 | 181 | 6 | GO:0008307 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 2.28e-05 | 38 | 181 | 5 | GO:0000146 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4-phosphate 5-kinase activity | 5.91e-05 | 9 | 181 | 3 | GO:0016308 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.01e-04 | 118 | 181 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH3 MYH8 MYH9 KIF27 MYO6 MYO1H SAE1 MCM2 YTHDC2 SMARCAD1 CHD5 ENTPD1 NAV1 DSCC1 ACSM6 DNAH11 | 1.55e-04 | 614 | 181 | 16 | GO:0140657 |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate 5-phosphatase activity | 1.96e-04 | 13 | 181 | 3 | GO:0034595 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-3-phosphate 5-kinase activity | 2.44e-04 | 3 | 181 | 2 | GO:0000285 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-5-kinase activity | 2.44e-04 | 3 | 181 | 2 | GO:0052810 | |
| GeneOntologyMolecularFunction | inositol trisphosphate phosphatase activity | 2.48e-04 | 14 | 181 | 3 | GO:0046030 | |
| GeneOntologyMolecularFunction | isomerase activity | PPIAL4C PPIAL4D PPIAL4H ECHS1 PPIAL4F PPIAL4E PPIAL4A PPIAL4G | 3.74e-04 | 192 | 181 | 8 | GO:0016853 |
| GeneOntologyMolecularFunction | inositol phosphate phosphatase activity | 7.45e-04 | 20 | 181 | 3 | GO:0052745 | |
| GeneOntologyMolecularFunction | protein-RNA adaptor activity | 1.29e-03 | 24 | 181 | 3 | GO:0140517 | |
| GeneOntologyMolecularFunction | phosphatidylinositol kinase activity | 1.63e-03 | 26 | 181 | 3 | GO:0052742 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity | 1.67e-03 | 7 | 181 | 2 | GO:0034485 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 3.58e-08 | 38 | 181 | 7 | GO:0000413 | |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 4.46e-07 | 54 | 181 | 7 | GO:0018208 | |
| GeneOntologyBiologicalProcess | cardiac muscle thin filament assembly | 6.65e-07 | 3 | 181 | 3 | GO:0071691 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | TPM2 MYH3 MYH9 SHROOM3 NRAP NEBL MYO6 CFL1 CFL2 MYO1H INPPL1 SPTA1 PCLO NEB PIP5K1C FER PIP5K1A CTTN CNN3 MYBPC1 | 2.72e-05 | 803 | 181 | 20 | GO:0030036 |
| GeneOntologyBiologicalProcess | actin filament organization | TPM2 MYH9 SHROOM3 NRAP NEBL MYO6 CFL1 CFL2 MYO1H INPPL1 SPTA1 NEB FER CTTN CNN3 | 4.53e-05 | 509 | 181 | 15 | GO:0007015 |
| GeneOntologyBiologicalProcess | actin filament-based process | TPM2 MYH3 MYH8 MYH9 SHROOM3 NRAP NEBL MYO6 CFL1 CFL2 MYO1H INPPL1 SPTA1 PCLO NEB PIP5K1C FER PIP5K1A CTTN CNN3 MYBPC1 | 5.32e-05 | 912 | 181 | 21 | GO:0030029 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | TPM2 KRT26 MYH3 MYH9 SHROOM3 MIA3 NRAP NEBL MYO6 CFL1 CFL2 MYO1H INPPL1 SPTA1 TOGARAM1 NEB CEP120 FER CTTN CNN3 MYBPC1 | 1.05e-04 | 957 | 181 | 21 | GO:0097435 |
| GeneOntologyBiologicalProcess | myofibril assembly | 1.10e-04 | 86 | 181 | 6 | GO:0030239 | |
| GeneOntologyBiologicalProcess | striated muscle cell development | 1.34e-04 | 89 | 181 | 6 | GO:0055002 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol biosynthetic process | 1.67e-04 | 132 | 181 | 7 | GO:0006661 | |
| GeneOntologyCellularComponent | actin cytoskeleton | TPM2 MYH3 MYH8 MYH9 SHROOM3 MYL5 NEBL MYO6 STK17B CFL1 CFL2 MYO1H INPP5D SPTA1 GBP3 NEB FER ADAM17 CTTN CNN3 | 1.46e-07 | 576 | 181 | 20 | GO:0015629 |
| GeneOntologyCellularComponent | supramolecular fiber | TPM2 KRT26 MYH3 MYH8 MYH9 SHROOM3 IGFN1 MYL5 NRAP KIF27 EFCAB6 NEBL MYO6 CFL2 INPP5D EML6 TOGARAM1 SYBU CMYA5 NEB RYR1 RMDN3 LRPPRC AKAP4 SYNJ1 NAV1 CTTN MYBPC1 DNAH11 | 3.45e-07 | 1179 | 181 | 29 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | TPM2 KRT26 MYH3 MYH8 MYH9 SHROOM3 IGFN1 MYL5 NRAP KIF27 EFCAB6 NEBL MYO6 CFL2 INPP5D EML6 TOGARAM1 SYBU CMYA5 NEB RYR1 RMDN3 LRPPRC AKAP4 SYNJ1 NAV1 CTTN MYBPC1 DNAH11 | 3.96e-07 | 1187 | 181 | 29 | GO:0099081 |
| GeneOntologyCellularComponent | contractile muscle fiber | TPM2 MYH3 MYH8 IGFN1 MYL5 NRAP NEBL CFL2 CMYA5 NEB RYR1 AKAP4 MYBPC1 | 1.56e-06 | 290 | 181 | 13 | GO:0043292 |
| GeneOntologyCellularComponent | sarcomere | TPM2 MYH3 MYH8 IGFN1 NRAP NEBL CFL2 CMYA5 NEB RYR1 AKAP4 MYBPC1 | 1.88e-06 | 249 | 181 | 12 | GO:0030017 |
| GeneOntologyCellularComponent | myofibril | TPM2 MYH3 MYH8 IGFN1 NRAP NEBL CFL2 CMYA5 NEB RYR1 AKAP4 MYBPC1 | 4.86e-06 | 273 | 181 | 12 | GO:0030016 |
| GeneOntologyCellularComponent | myosin complex | 1.19e-05 | 59 | 181 | 6 | GO:0016459 | |
| GeneOntologyCellularComponent | myosin filament | 5.97e-05 | 25 | 181 | 4 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 9.46e-05 | 28 | 181 | 4 | GO:0016460 | |
| GeneOntologyCellularComponent | cell cortex | MYH9 SHROOM3 MYO6 CFL1 INPP5D SPTA1 PCLO RYR1 PARD6B FER OSBPL8 CTTN | 9.91e-05 | 371 | 181 | 12 | GO:0005938 |
| GeneOntologyCellularComponent | nuclear speck | IL16 RBBP6 CDK12 INPPL1 NOC3L CMYA5 THOC2 YTHDC1 ADAR VIRMA RBM19 CHD5 PIP5K1A | 1.03e-04 | 431 | 181 | 13 | GO:0016607 |
| GeneOntologyCellularComponent | cortical cytoskeleton | 1.34e-04 | 129 | 181 | 7 | GO:0030863 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | MYH9 PHF20 ARID4A CDK12 RANBP3 HMGXB4 SAE1 MCM2 ICE1 RBM28 CHRAC1 THOC2 ADAR ZC3H3 HEXIM1 JARID2 BAZ1A TLE4 CHD5 CSTF1 PIP5K1A BOD1L1 MPHOSPH10 NUP188 TAF9 DSCC1 | 1.44e-04 | 1377 | 181 | 26 | GO:0140513 |
| GeneOntologyCellularComponent | uropod | 2.17e-04 | 14 | 181 | 3 | GO:0001931 | |
| GeneOntologyCellularComponent | ISWI-type complex | 2.17e-04 | 14 | 181 | 3 | GO:0031010 | |
| GeneOntologyCellularComponent | cell trailing edge | 2.69e-04 | 15 | 181 | 3 | GO:0031254 | |
| GeneOntologyCellularComponent | muscle myosin complex | 3.29e-04 | 16 | 181 | 3 | GO:0005859 | |
| GeneOntologyCellularComponent | Z disc | 3.52e-04 | 151 | 181 | 7 | GO:0030018 | |
| GeneOntologyCellularComponent | CHRAC | 4.42e-04 | 4 | 181 | 2 | GO:0008623 | |
| GeneOntologyCellularComponent | cell-substrate junction | MYH9 IL16 NRAP CFL1 RPS5 PIP5K1C ITGB8 LMO7 PIP5K1A ADAM17 CTTN CNN3 | 5.01e-04 | 443 | 181 | 12 | GO:0030055 |
| GeneOntologyCellularComponent | I band | 6.20e-04 | 166 | 181 | 7 | GO:0031674 | |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 1.29e-03 | 93 | 181 | 5 | GO:0030864 | |
| GeneOntologyCellularComponent | focal adhesion | MYH9 IL16 CFL1 RPS5 PIP5K1C ITGB8 LMO7 PIP5K1A ADAM17 CTTN CNN3 | 1.38e-03 | 431 | 181 | 11 | GO:0005925 |
| GeneOntologyCellularComponent | heterochromatin | 1.87e-03 | 101 | 181 | 5 | GO:0000792 | |
| GeneOntologyCellularComponent | glutamatergic synapse | TRIO MYO6 CFL1 PCLO ZDHHC5 DOCK10 RTN3 PIP5K1C RGS7 SHISA9 SYNJ1 CTTN ADGRL2 PLXNA1 CNN3 TPD52 | 2.03e-03 | 817 | 181 | 16 | GO:0098978 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | TPM2 KRT26 MYH9 SHROOM3 KIF27 EFCAB6 MYO6 INPP5D EML6 TOGARAM1 SYBU RMDN3 LRPPRC SYNJ1 NAV1 CTTN DNAH11 | 2.14e-03 | 899 | 181 | 17 | GO:0099513 |
| GeneOntologyCellularComponent | ruffle | 2.16e-03 | 206 | 181 | 7 | GO:0001726 | |
| GeneOntologyCellularComponent | nuclear body | MYH9 IL16 RBBP6 CDK12 INPPL1 NOC3L NCAM2 ICE1 CMYA5 THOC2 YTHDC1 ADAR VIRMA RBM19 CHD5 PIP5K1A XRRA1 | 2.24e-03 | 903 | 181 | 17 | GO:0016604 |
| GeneOntologyCellularComponent | mRNA cleavage factor complex | 2.40e-03 | 31 | 181 | 3 | GO:0005849 | |
| GeneOntologyCellularComponent | leading edge membrane | 2.41e-03 | 210 | 181 | 7 | GO:0031256 | |
| GeneOntologyCellularComponent | methyltransferase complex | 2.50e-03 | 108 | 181 | 5 | GO:0034708 | |
| GeneOntologyCellularComponent | ruffle membrane | 2.50e-03 | 108 | 181 | 5 | GO:0032587 | |
| GeneOntologyCellularComponent | adherens junction | 2.54e-03 | 212 | 181 | 7 | GO:0005912 | |
| HumanPheno | Axial muscle weakness | 1.17e-06 | 50 | 58 | 7 | HP:0003327 | |
| HumanPheno | Abnormal axial muscle morphology | 1.54e-06 | 52 | 58 | 7 | HP:0040286 | |
| HumanPheno | Muscle stiffness | 3.50e-06 | 83 | 58 | 8 | HP:0003552 | |
| HumanPheno | Nemaline bodies | 5.16e-05 | 19 | 58 | 4 | HP:0003798 | |
| HumanPheno | Exercise-induced myalgia | 5.30e-05 | 37 | 58 | 5 | HP:0003738 | |
| HumanPheno | Fatigable weakness of distal limb muscles | 7.54e-05 | 8 | 58 | 3 | HP:0030198 | |
| HumanPheno | Type 1 muscle fiber predominance | 8.97e-05 | 66 | 58 | 6 | HP:0003803 | |
| HumanPheno | Multiple joint contractures | 1.25e-04 | 70 | 58 | 6 | HP:0002828 | |
| Domain | Cyclophilin-type_PPIase_CS | 6.55e-07 | 19 | 172 | 5 | IPR020892 | |
| Domain | Cyclophilin-type_PPIase | 1.13e-06 | 21 | 172 | 5 | IPR024936 | |
| Domain | Pro_isomerase | 1.45e-06 | 22 | 172 | 5 | PF00160 | |
| Domain | Cyclophilin-type_PPIase_dom | 1.45e-06 | 22 | 172 | 5 | IPR002130 | |
| Domain | Cyclophilin-like_dom | 1.45e-06 | 22 | 172 | 5 | IPR029000 | |
| Domain | CSA_PPIASE_2 | 1.45e-06 | 22 | 172 | 5 | PS50072 | |
| Domain | - | 1.45e-06 | 22 | 172 | 5 | 2.40.100.10 | |
| Domain | CSA_PPIASE_1 | 1.45e-06 | 22 | 172 | 5 | PS00170 | |
| Domain | Nebulin | 3.05e-06 | 4 | 172 | 3 | PF00880 | |
| Domain | NEBULIN | 3.05e-06 | 4 | 172 | 3 | PS51216 | |
| Domain | NEBU | 3.05e-06 | 4 | 172 | 3 | SM00227 | |
| Domain | Nebulin | 3.05e-06 | 4 | 172 | 3 | IPR013998 | |
| Domain | Nebulin_repeat | 3.05e-06 | 4 | 172 | 3 | IPR000900 | |
| Domain | PInositol-4-P-5-kinase | 2.61e-05 | 7 | 172 | 3 | IPR023610 | |
| Domain | PIPKc | 4.15e-05 | 8 | 172 | 3 | SM00330 | |
| Domain | - | 4.15e-05 | 8 | 172 | 3 | 3.30.800.10 | |
| Domain | PIP5K | 4.15e-05 | 8 | 172 | 3 | PF01504 | |
| Domain | PIPK | 4.15e-05 | 8 | 172 | 3 | PS51455 | |
| Domain | PInositol-4-P-5-kinase_N | 4.15e-05 | 8 | 172 | 3 | IPR027484 | |
| Domain | PInositol-4-P-5-kinase_C | 4.15e-05 | 8 | 172 | 3 | IPR027483 | |
| Domain | - | 4.15e-05 | 8 | 172 | 3 | 3.30.810.10 | |
| Domain | PInositol-4-P-5-kinase_core | 4.15e-05 | 8 | 172 | 3 | IPR002498 | |
| Domain | IPPc | 8.78e-05 | 10 | 172 | 3 | IPR000300 | |
| Domain | IPPc | 8.78e-05 | 10 | 172 | 3 | SM00128 | |
| Domain | ADF/Cofilin | 2.51e-04 | 3 | 172 | 2 | IPR017904 | |
| Domain | Myosin_N | 3.22e-04 | 15 | 172 | 3 | PF02736 | |
| Domain | Myosin_N | 3.22e-04 | 15 | 172 | 3 | IPR004009 | |
| Domain | Myosin_head_motor_dom | 4.02e-04 | 38 | 172 | 4 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 4.02e-04 | 38 | 172 | 4 | PS51456 | |
| Domain | Myosin_head | 4.02e-04 | 38 | 172 | 4 | PF00063 | |
| Domain | MYSc | 4.02e-04 | 38 | 172 | 4 | SM00242 | |
| Domain | Myosin_tail_1 | 5.66e-04 | 18 | 172 | 3 | PF01576 | |
| Domain | Myosin_tail | 5.66e-04 | 18 | 172 | 3 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 6.67e-04 | 19 | 172 | 3 | IPR027401 | |
| Domain | - | 6.67e-04 | 19 | 172 | 3 | 4.10.270.10 | |
| Domain | fn3 | 7.66e-04 | 162 | 172 | 7 | PF00041 | |
| Domain | YTH | 8.28e-04 | 5 | 172 | 2 | PF04146 | |
| Domain | YTH_domain | 8.28e-04 | 5 | 172 | 2 | IPR007275 | |
| Domain | DUF4704 | 8.28e-04 | 5 | 172 | 2 | IPR031570 | |
| Domain | DUF4704 | 8.28e-04 | 5 | 172 | 2 | PF15787 | |
| Domain | YTH | 8.28e-04 | 5 | 172 | 2 | PS50882 | |
| Domain | ARM-type_fold | SMG1 NBEAL1 HEATR4 NOC3L TOGARAM1 VIRMA ARFGEF3 AP4E1 NBEAL2 NUP188 | 1.22e-03 | 339 | 172 | 10 | IPR016024 |
| Domain | PH_BEACH | 1.23e-03 | 6 | 172 | 2 | PF14844 | |
| Domain | FN3 | 1.66e-03 | 185 | 172 | 7 | SM00060 | |
| Domain | - | 1.71e-03 | 26 | 172 | 3 | 3.60.10.10 | |
| Domain | Exo_endo_phos | 1.71e-03 | 26 | 172 | 3 | PF03372 | |
| Domain | Endo/exonuclease/phosphatase | 1.91e-03 | 27 | 172 | 3 | IPR005135 | |
| Domain | Ig_I-set | 1.93e-03 | 190 | 172 | 7 | IPR013098 | |
| Domain | I-set | 1.93e-03 | 190 | 172 | 7 | PF07679 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | 4.75e-06 | 50 | 124 | 6 | MM14641 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | 6.72e-06 | 53 | 124 | 6 | M662 | |
| Pathway | REACTOME_STRIATED_MUSCLE_CONTRACTION | 1.28e-05 | 35 | 124 | 5 | MM15005 | |
| Pathway | REACTOME_STRIATED_MUSCLE_CONTRACTION | 1.47e-05 | 36 | 124 | 5 | M18647 | |
| Pathway | WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY | 1.93e-05 | 38 | 124 | 5 | M39549 | |
| Pathway | KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM | 5.42e-05 | 76 | 124 | 6 | M9052 | |
| Pathway | REACTOME_PI_METABOLISM | 5.84e-05 | 77 | 124 | 6 | MM14590 | |
| Pathway | REACTOME_PI_METABOLISM | 9.52e-05 | 84 | 124 | 6 | M676 | |
| Pathway | KEGG_INOSITOL_PHOSPHATE_METABOLISM | 1.09e-04 | 54 | 124 | 5 | M3896 | |
| Pathway | REACTOME_MEMBRANE_TRAFFICKING | MYH9 MIA3 KIF27 MYO6 SPTA1 PIP5K1C TBC1D8B RAB41 AP4E1 SYNJ1 LNPEP TMED10 CTTN TRAPPC9 GOLGA4 TPD52 | 1.27e-04 | 630 | 124 | 16 | M11480 |
| Pathway | KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS | 1.99e-04 | 96 | 124 | 6 | M16121 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MYH9 KIF27 TRIO MYO6 CFL1 RPS5 PCLO NOC3L RTN3 MCM2 YTHDC2 SMARCAD1 PFKM CMYA5 THOC2 LDHA ECHS1 ADAR LETM1 HEXIM1 JARID2 SCAF1 LRPPRC GCLC BAZ1A RBM19 CSTF1 BOD1L1 NUP188 CTTN PLXNA1 GOLGA4 MYBPC1 | 6.22e-13 | 1425 | 182 | 33 | 30948266 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | PPIAL4D ARID4A RBBP6 CDK12 CFL1 RPS5 CFL2 HMGXB4 NOC3L ICE1 RBM28 THOC2 LDHA ADAR NKRF PPIAL4F BAZ1A PRRC2C RBM19 PPIAL4A BOD1L1 MPHOSPH10 TAF9 CTTN PPIAL4G | 4.07e-11 | 954 | 182 | 25 | 36373674 |
| Pubmed | 2.05e-10 | 8 | 182 | 5 | 20622009 | ||
| Pubmed | MIA3 NEBL TRIO CDK12 ICE1 HMGCR RBM28 TEX9 CLCC1 CEMIP2 CEP350 SLC12A2 OSBPL8 NAV1 DNAJC5 DCLRE1A BOD1L1 TMEM131 EIF3G TMED10 GOLGA4 | 3.39e-10 | 733 | 182 | 21 | 34672954 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | SDK2 RBBP6 CDK12 HMGXB4 ZDHHC5 TOGARAM1 YTHDC2 ICE1 YTHDC1 ARFGEF3 SCAF1 LMO7 BAZ1A PRRC2C RBM19 | 9.20e-10 | 361 | 182 | 15 | 26167880 |
| Pubmed | TPM2 CYLC1 EFCAB5 SMG1 MYH3 MYH8 MYH9 CFL1 RPS5 CFL2 SPTA1 PCLO EML6 NOC3L PFKM NEB LETM1 LRPPRC LMO7 GCLC BAZ1A PRRC2C CHD5 DNAJC5 BOD1L1 MPHOSPH10 CTTN MYBPC1 | 2.27e-09 | 1442 | 182 | 28 | 35575683 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MYH9 NEBL MYO6 RBBP6 CDK12 CFL1 RANBP3 NOC3L YTHDC2 ICE1 PFKM THOC2 LDHA ADAR NKRF SYNJ1 BAZ1A PRRC2C BOD1L1 EIF3G CTTN CNN3 | 4.65e-09 | 934 | 182 | 22 | 33916271 |
| Pubmed | MYH9 IL16 TRIO MYO6 CFL1 RPS5 CFL2 SPTA1 PCLO RTN3 NCAM2 YTHDC2 PFKM LDHA VIRMA LETM1 LRPPRC SYNJ1 LMO7 PRRC2C SORCS2 OSBPL8 NAV1 CTTN PCDH1 TRAPPC9 DNAH11 | 8.30e-09 | 1431 | 182 | 27 | 37142655 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | MYH9 SHROOM3 NEBL MYO6 INPPL1 ZDHHC5 LDHA CEMIP2 SLC12A2 SYNJ1 LMO7 ADAM17 CTTN ADGRL2 PCDH1 CNN3 TPD52 | 8.73e-09 | 565 | 182 | 17 | 25468996 |
| Pubmed | MYH9 MIA3 ARID4A NBEAL1 RANBP3 YTHDC2 CLCC1 CEMIP2 RMDN3 SLC12A2 PRRC2C OSBPL8 TMEM131 EIF3G CTTN GOLGA4 TPD52 | 9.44e-09 | 568 | 182 | 17 | 37774976 | |
| Pubmed | SHROOM3 NEBL RBBP6 CDK12 HMGXB4 NOC3L YTHDC2 ICE1 YTHDC1 VIRMA NKRF HEXIM1 PARD6B JARID2 RMDN3 SCAF1 GUF1 SLC12A2 BAZ1A LNPEP RBM19 OSBPL8 CSTF1 MPHOSPH10 EIF3G TMED10 TAF9 | 2.12e-08 | 1497 | 182 | 27 | 31527615 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | TPM2 MYH9 MIA3 MYO6 CFL1 RPS5 CFL2 SAE1 MCM2 RBM28 PFKM THOC2 LDHA ADAR PRRC2C DNAJC5 BOD1L1 EIF3G TMED10 CTTN | 2.35e-08 | 847 | 182 | 20 | 35235311 |
| Pubmed | MYH9 SHROOM3 EFCAB6 MYO6 RPS5 NOC3L ZDHHC5 TEX9 LDHA CLCC1 CEMIP2 CEP350 ARFGEF3 AP4E1 SLC12A2 RBM19 DCLRE1A ADGRL2 GOLGA4 | 3.12e-08 | 777 | 182 | 19 | 35844135 | |
| Pubmed | TPM2 SMG1 CFL2 NOC3L MCM2 YTHDC2 HMGCR RBM28 PFKM THOC2 LDHA NKRF LETM1 CLCC1 ARFGEF3 LRPPRC LMO7 PRRC2C OSBPL8 ING4 NUP188 EIF3G TMED10 CTTN ADGRL2 TRAPPC9 | 3.90e-08 | 1440 | 182 | 26 | 30833792 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MYH9 MYO6 RBBP6 CFL1 RPS5 CFL2 NOC3L YTHDC2 RBM28 THOC2 LDHA YTHDC1 ADAR VIRMA NKRF LRPPRC LMO7 PRRC2C RBM19 CHD5 NAV1 MPHOSPH10 EIF3G CTTN | 4.89e-08 | 1257 | 182 | 24 | 36526897 |
| Pubmed | SHROOM3 MIA3 MYO6 RANBP3 NOC3L ZDHHC5 RTN3 SMARCAD1 RBM28 PFKM ECHS1 LETM1 CLCC1 CEMIP2 GUF1 LRPPRC SLC12A2 LNPEP OSBPL8 PIP5K1A DNAJC5 TMEM131 TMED10 ADGRL2 GOLGA4 TPD52 | 7.33e-08 | 1487 | 182 | 26 | 33957083 | |
| Pubmed | TPM2 MYH9 MIA3 TRIO RBBP6 CFL1 RPS5 RTN3 MCM2 SMARCAD1 PFKM LDHA ADAR LRPPRC BAZ1A LNPEP PRRC2C OSBPL8 CSTF1 CNPY3 PIP5K1A BOD1L1 NUP188 TMED10 | 8.73e-08 | 1297 | 182 | 24 | 33545068 | |
| Pubmed | 1.41e-07 | 3 | 182 | 3 | 14681219 | ||
| Pubmed | PIP5KIβ selectively modulates apical endocytosis in polarized renal epithelial cells. | 1.41e-07 | 3 | 182 | 3 | 23342003 | |
| Pubmed | 1.41e-07 | 3 | 182 | 3 | 22942276 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SHROOM3 TRIO RANBP3 INPPL1 RAB11FIP2 VIRMA CEP350 ARFGEF3 LRPPRC SLC12A2 SYNJ1 LMO7 PRRC2C OSBPL8 NAV1 BOD1L1 MUSK TRAPPC9 GOLGA4 | 1.54e-07 | 861 | 182 | 19 | 36931259 |
| Pubmed | MIA3 MYO6 RPS5 RAB11FIP2 ZDHHC5 RTN3 MCM2 LDHA CLCC1 CEMIP2 AP4E1 SLC12A2 LNPEP OSBPL8 TMEM131 ADAM17 TMED10 HSD17B11 PLXNA1 GOLGA4 | 1.56e-07 | 952 | 182 | 20 | 38569033 | |
| Pubmed | MYH9 MYO6 CFL1 RPS5 ZDHHC5 YTHDC2 LETM1 CLCC1 LRPPRC PRRC2C OSBPL8 BOD1L1 EIF3G CTTN ADGRL2 CNN3 GOLGA4 | 2.23e-07 | 708 | 182 | 17 | 39231216 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | TPM2 MYH9 CFL1 RPS5 RANBP3 NOC3L PFKM LDHA ECHS1 ADAR SERPINA12 CLCC1 HEXIM1 RMDN3 NLN LRPPRC RBM19 PIP5K1A EIF3G TMED10 CTTN HSD17B11 CNN3 TPD52 | 2.28e-07 | 1367 | 182 | 24 | 32687490 |
| Pubmed | MYH9 MIA3 MYO6 CFL1 RPS5 ZDHHC5 DOCK10 LDHA ADAR CLCC1 CEP350 LRPPRC LNPEP PRRC2C RBM19 NBEAL2 CHD5 ENTPD1 OSBPL8 DNAJC5 ADAM17 NUP188 | 2.34e-07 | 1168 | 182 | 22 | 19946888 | |
| Pubmed | TPM2 MYH9 MYO6 CDK12 CFL1 SAE1 RBM28 WDR76 THOC2 LDHA ECHS1 TBC1D8B VIRMA NKRF CEP350 PARD6B SCAF1 LMO7 BAZ1A PRRC2C RBM19 OSBPL8 C5 TAF9 | 2.40e-07 | 1371 | 182 | 24 | 36244648 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | SMG1 MYH9 RBBP6 RPS5 NOC3L YTHDC2 RBM28 YTHDC1 ADAR VIRMA NKRF LRPPRC PRRC2C RBM19 CSTF1 MPHOSPH10 EIF3G NOVA2 | 2.84e-07 | 807 | 182 | 18 | 22681889 |
| Pubmed | MYH9 SHROOM3 RBBP6 CDK12 CFL1 RPS5 NOC3L YTHDC2 RBM28 THOC2 LDHA ADAR VIRMA NKRF PRRC2C EIF3G NOVA2 | 3.47e-07 | 731 | 182 | 17 | 29298432 | |
| Pubmed | TRIO INPPL1 RAB11FIP2 ZDHHC5 MCM2 RGS7 CEMIP2 PARD6B LRPPRC SLC12A2 OSBPL8 PIP5K1A ADGRL2 | 3.91e-07 | 421 | 182 | 13 | 36976175 | |
| Pubmed | RTN3 CLCC1 CEMIP2 ARFGEF3 RMDN3 SLC12A2 TYW1B LNPEP OSBPL8 TMEM131 ADAM17 ADGRL2 PLXNA1 GOLGA4 | 4.92e-07 | 504 | 182 | 14 | 34432599 | |
| Pubmed | 5.62e-07 | 4 | 182 | 3 | 18188447 | ||
| Pubmed | Identification and characterization of a phosphoinositide phosphate kinase homolog. | 5.62e-07 | 4 | 182 | 3 | 14701839 | |
| Pubmed | 5.62e-07 | 4 | 182 | 3 | 9535851 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | SMG1 MIA3 RPS5 NOC3L MCM2 YTHDC2 RBM28 ADAR NKRF HASPIN MPHOSPH10 NUP188 CTTN | 6.43e-07 | 440 | 182 | 13 | 34244565 |
| Pubmed | MYO6 NOC3L SAE1 MCM2 LDHA YTHDC1 PIP5K1C ECHS1 ADAR CLCC1 NLN LRPPRC PPIAL4A EIF3G TMED10 CTTN TPD52 | 9.42e-07 | 786 | 182 | 17 | 29128334 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | MIA3 MYO6 CFL2 PCLO RTN3 YTHDC2 SYBU RBM28 PFKM ECHS1 NKRF LETM1 CLCC1 ARFGEF3 RMDN3 GUF1 LRPPRC SLC12A2 OSBPL8 NAV1 TMEM131 MPHOSPH10 NUP188 TMED10 | 1.13e-06 | 1496 | 182 | 24 | 32877691 |
| Pubmed | CDK7/GRP78 signaling axis contributes to tumor growth and metastasis in osteosarcoma. | MYH9 MYO6 CFL1 RPS5 SMARCAD1 CHRAC1 ECHS1 LETM1 LRPPRC LMO7 TMED10 CTTN CNN3 | 1.28e-06 | 468 | 182 | 13 | 36042349 |
| Pubmed | RBBP6 CDK12 CFL1 RANBP3 THOC2 ADAR NKRF SYNJ1 LMO7 PRRC2C BOD1L1 CTTN CNN3 TPD52 | 1.35e-06 | 549 | 182 | 14 | 38280479 | |
| Pubmed | The lipid kinase PIP5K1C regulates pain signaling and sensitization. | 1.40e-06 | 5 | 182 | 3 | 24853942 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SHROOM3 TRIO CDK12 CFL1 INPPL1 ZDHHC5 ICE1 PIP5K1C RYR1 SCAF1 SYNJ1 RBM19 NBEAL2 NEK8 CHD5 NAV1 ZFYVE26 NUP188 PLXNA1 TRAPPC9 | 1.58e-06 | 1105 | 182 | 20 | 35748872 |
| Pubmed | TPM2 MYH9 TRIO EML6 SAE1 ADAR LETM1 PRRC2C NAV1 EIF3G ADGRL2 | 1.59e-06 | 332 | 182 | 11 | 37433992 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | MYH9 RBBP6 CFL1 RPS5 NOC3L SAE1 MCM2 RBM28 THOC2 LDHA YTHDC1 ECHS1 ADAR NKRF SCAF1 GUF1 LRPPRC OSBPL8 MPHOSPH10 EIF3G TMED10 TAF9 | 1.74e-06 | 1318 | 182 | 22 | 30463901 |
| Pubmed | Prdm16 is required for the maintenance of brown adipocyte identity and function in adult mice. | 1.85e-06 | 39 | 182 | 5 | 24703692 | |
| Pubmed | MYH9 RBBP6 CFL1 RPS5 NOC3L MCM2 SYBU RBM28 THOC2 YTHDC1 ADAR NKRF HEXIM1 LMO7 BAZ1A CSTF1 MPHOSPH10 | 2.58e-06 | 847 | 182 | 17 | 35850772 | |
| Pubmed | Branches of the B cell antigen receptor pathway are directed by protein conduits Bam32 and Carma1. | 2.79e-06 | 6 | 182 | 3 | 14614850 | |
| Pubmed | 2.79e-06 | 6 | 182 | 3 | 20841379 | ||
| Pubmed | 2.79e-06 | 6 | 182 | 3 | 28581524 | ||
| Pubmed | 2.79e-06 | 6 | 182 | 3 | 15123724 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | TPM2 MYH9 MYO6 RBBP6 CFL1 RPS5 NOC3L RBM28 THOC2 LDHA YTHDC1 ADAR NKRF LRPPRC LMO7 CHD5 MPHOSPH10 CTTN | 2.84e-06 | 949 | 182 | 18 | 36574265 |
| Pubmed | KRT26 MYH9 CDK12 CFL1 RPS5 CFL2 MCM2 YTHDC2 LDHA PIP5K1C NKRF HEXIM1 LRPPRC TTLL2 CHD5 PPIAL4A PIP5K1A PIP5K1B EIF3G TAF9 | 3.00e-06 | 1153 | 182 | 20 | 29845934 | |
| Pubmed | MYH9 MYO6 RBBP6 CDK12 CFL1 RPS5 CFL2 SYNJ1 LMO7 CSTF1 BOD1L1 CTTN CNN3 | 3.00e-06 | 506 | 182 | 13 | 30890647 | |
| Pubmed | 3.17e-06 | 225 | 182 | 9 | 12168954 | ||
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | RBBP6 CDK12 RPS5 NOC3L YTHDC2 RBM28 YTHDC1 NKRF LRPPRC PRRC2C RBM19 PIP5K1A MPHOSPH10 EIF3G TRAPPC9 | 3.21e-06 | 678 | 182 | 15 | 30209976 |
| Pubmed | 4.37e-06 | 234 | 182 | 9 | 36243803 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | MYH9 PHF20 ARID4A RBBP6 RPS5 SPTA1 HMGXB4 RBM28 CHRAC1 WDR76 THOC2 YTHDC1 ADAR NKRF SCAF1 LMO7 BAZ1A ING4 DCLRE1A NUP188 TAF9 | 4.69e-06 | 1294 | 182 | 21 | 30804502 |
| Pubmed | 4.86e-06 | 7 | 182 | 3 | 15018809 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | MYH9 CFL1 RPS5 NOC3L MCM2 RBM28 THOC2 YTHDC1 ADAR NKRF HEXIM1 SCAF1 LRPPRC RBM19 BOD1L1 MPHOSPH10 TAF9 CNN3 | 5.02e-06 | 989 | 182 | 18 | 36424410 |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | MYH9 SHROOM3 PHF20 RANBP3 MGAT4A YTHDC1 JARID2 NLN DNAJC5 TSTD2 TMED10 TAF9 CNN3 | 5.59e-06 | 536 | 182 | 13 | 15840001 |
| Pubmed | MYH9 SHROOM3 PHF20 RANBP3 MGAT4A YTHDC1 JARID2 NLN DNAJC5 TSTD2 TMED10 TAF9 CNN3 | 5.82e-06 | 538 | 182 | 13 | 10512203 | |
| Pubmed | MYH9 RBBP6 CDK12 RPS5 YTHDC2 RBM28 THOC2 YTHDC1 ADAR NKRF HEXIM1 PRRC2C CSTF1 PIP5K1A MPHOSPH10 | 5.88e-06 | 713 | 182 | 15 | 29802200 | |
| Pubmed | SDK2 MIA3 RAB11FIP2 ZDHHC5 ECHS1 CLCC1 CEMIP2 SLC12A2 SYNJ1 TLE4 OSBPL8 CSTF1 CNPY3 PIP5K1A TMEM131 EIF3G TMED10 TAF9 | 6.42e-06 | 1007 | 182 | 18 | 34597346 | |
| Pubmed | SIK2 orchestrates actin-dependent host response upon Salmonella infection. | 6.50e-06 | 50 | 182 | 5 | 33947818 | |
| Pubmed | MYH9 RBBP6 CDK12 SAE1 MCM2 SMARCAD1 THOC2 YTHDC1 ADAR VIRMA NKRF HEXIM1 BAZ1A CSTF1 BOD1L1 EIF3G TAF9 CTTN | 7.06e-06 | 1014 | 182 | 18 | 32416067 | |
| Pubmed | ZFP36L2 is a cell cycle-regulated CCCH protein necessary for DNA lesion-induced S-phase arrest. | 7.49e-06 | 189 | 182 | 8 | 29449217 | |
| Pubmed | 7.74e-06 | 8 | 182 | 3 | 15046600 | ||
| Pubmed | Skeletal muscle phenotypes initiated by ectopic MyoD in transgenic mouse heart. | 7.74e-06 | 8 | 182 | 3 | 1618148 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CFL1 RPS5 MCM2 YTHDC2 RBM28 THOC2 LDHA ECHS1 ADAR NKRF CEP350 SCAF1 LRPPRC SLC12A2 LMO7 BAZ1A NUP188 CTTN | 8.06e-06 | 1024 | 182 | 18 | 24711643 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | TPM2 MYH9 CFL1 RPS5 RANBP3 INPPL1 TPRKB SAE1 MCM2 SMARCAD1 CHRAC1 PFKM CMYA5 LDHA ECHS1 HEXIM1 GCLC LNPEP NUP188 EIF3G CTTN TPD52 | 8.38e-06 | 1455 | 182 | 22 | 22863883 |
| Pubmed | 9.54e-06 | 54 | 182 | 5 | 22266860 | ||
| Pubmed | MYH9 RBBP6 CFL1 RPS5 NOC3L MCM2 THOC2 LDHA ADAR SERPINA12 LRPPRC LMO7 DCLRE1A TMED10 | 9.66e-06 | 652 | 182 | 14 | 31180492 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MYH9 MYO6 CDK12 CFL1 RPS5 CFL2 SAE1 MCM2 LDHA ECHS1 ADAR LRPPRC LMO7 PRRC2C EIF3G TMED10 CTTN CNN3 TPD52 | 1.06e-05 | 1149 | 182 | 19 | 35446349 |
| Pubmed | NOC3L YTHDC2 RBM28 YTHDC1 ADAR NKRF RBM19 OSBPL8 MPHOSPH10 NUP188 | 1.10e-05 | 332 | 182 | 10 | 25693804 | |
| Pubmed | 1.16e-05 | 9 | 182 | 3 | 22976293 | ||
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | SDK2 BTBD6 CDK12 CFL1 ZDHHC5 LDHA NKRF CEP350 RMDN3 GCLC TLE4 OSBPL8 NUP188 USH2A | 1.31e-05 | 670 | 182 | 14 | 22990118 |
| Pubmed | RPS5 RAB11FIP2 ZDHHC5 LDHA CEMIP2 LNPEP EIF3G CTTN CNN3 GOLGA4 | 1.32e-05 | 339 | 182 | 10 | 37232246 | |
| Pubmed | TPM2 SMG1 MYH3 MYH8 NRAP TRIO TPRKB CMYA5 NEB RYR1 LRPPRC MYBPC1 | 1.35e-05 | 497 | 182 | 12 | 23414517 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ARID4A RBBP6 CDK12 MCM2 YTHDC2 SMARCAD1 THOC2 YTHDC1 VIRMA SCAF1 LMO7 TLE4 EIF3G CTTN GOLGA4 | 1.55e-05 | 774 | 182 | 15 | 15302935 |
| Pubmed | Nemaline Myopathy – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY | 1.65e-05 | 10 | 182 | 3 | 20301465 | |
| Pubmed | IL16 TRIO NBEAL1 RPS5 INPPL1 LDHA LETM1 CEP350 RMDN3 CEP120 SYNJ1 CSTF1 EIF3G DNAH11 | 1.78e-05 | 689 | 182 | 14 | 36543142 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | SHROOM3 RBBP6 RANBP3 INPP5D INPPL1 SMARCAD1 PIP5K1C FAM186B SLC12A2 CHD5 IGSF9B | 1.83e-05 | 430 | 182 | 11 | 35044719 |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | MIA3 RBBP6 CDK12 NOC3L ZDHHC5 RTN3 THOC2 YTHDC1 VIRMA LETM1 CLCC1 CEMIP2 SLC12A2 OSBPL8 ADAM17 NUP188 TMED10 HSD17B11 NOVA2 | 1.99e-05 | 1203 | 182 | 19 | 29180619 |
| Pubmed | Interactome Analysis of the Nucleocapsid Protein of SARS-CoV-2 Virus. | 2.19e-05 | 159 | 182 | 7 | 34578187 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 2.26e-05 | 361 | 182 | 10 | 30344098 | |
| Pubmed | MYO6 RPS5 PFKM LDHA ADAR CEMIP2 LRPPRC LNPEP TMEM131 ADAM17 TMED10 HSD17B11 PLXNA1 | 2.30e-05 | 613 | 182 | 13 | 22268729 | |
| Pubmed | MYH9 CFL1 RPS5 CFL2 SH3BGRL NOC3L SAE1 MCM2 RBM28 PFKM LDHA ECHS1 LRPPRC TMED10 GOLGA4 | 2.36e-05 | 803 | 182 | 15 | 36517590 | |
| Pubmed | SMG1 SHROOM3 SDK2 CDK12 MCM2 ICE1 CEMIP2 LMO7 NBEAL2 CHD5 NUP188 ADGRL2 | 2.49e-05 | 529 | 182 | 12 | 14621295 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 24023293 | ||
| Pubmed | PI4P5-kinase Ialpha is required for efficient HIV-1 entry and infection of T cells. | 2.72e-05 | 2 | 182 | 2 | 18981107 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 8800436 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 19549683 | ||
| Pubmed | Regulation of inositol 5-phosphatase activity by the C2 domain of SHIP1 and SHIP2. | 2.72e-05 | 2 | 182 | 2 | 38309262 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 30662943 | ||
| Pubmed | Type Ialpha phosphatidylinositol-4-phosphate 5-kinase mediates Rac-dependent actin assembly. | 2.72e-05 | 2 | 182 | 2 | 10679324 | |
| Pubmed | Cloning of cDNAs encoding two isoforms of 68-kDa type I phosphatidylinositol-4-phosphate 5-kinase. | 2.72e-05 | 2 | 182 | 2 | 8798574 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 15728183 | ||
| Pubmed | Phosphatidylinositol phosphate kinases, a multifaceted family of signaling enzymes. | 2.72e-05 | 2 | 182 | 2 | 10187762 | |
| Pubmed | Type I phosphotidylinosotol 4-phosphate 5-kinase γ regulates osteoclasts in a bifunctional manner. | 2.72e-05 | 2 | 182 | 2 | 23300084 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 38372449 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 19839650 | ||
| Pubmed | PIP5K-driven PtdIns(4,5)P2 synthesis: regulation and cellular functions. | 2.72e-05 | 2 | 182 | 2 | 19889969 | |
| Interaction | RAB11A interactions | MYH9 SDK2 TRIO RAB11FIP2 ZDHHC5 RTN3 RBM28 VIRMA NKRF CLCC1 CEMIP2 HEXIM1 AP4E1 SLC12A2 LNPEP NBEAL2 OSBPL8 DNAJC5 EIF3G CTTN HSD17B11 TRAPPC9 CNN3 GOLGA4 TPD52 | 8.26e-08 | 830 | 178 | 25 | int:RAB11A |
| Interaction | H2BC12 interactions | CYLC1 MYH9 SHROOM3 MYO1H PCLO SAE1 MCM2 NEB WDR76 VIRMA HEXIM1 CEP350 SCAF1 AKAP4 CHD5 | 1.86e-07 | 322 | 178 | 15 | int:H2BC12 |
| Interaction | PGBD5 interactions | 2.02e-07 | 7 | 178 | 4 | int:PGBD5 | |
| Interaction | SRPK2 interactions | SDK2 RBBP6 CDK12 HMGXB4 NOC3L ZDHHC5 TOGARAM1 YTHDC2 RBM28 LDHA YTHDC1 ADAR VIRMA NKRF ARFGEF3 SCAF1 LMO7 BAZ1A PRRC2C RBM19 TLE4 TPD52 | 3.89e-07 | 717 | 178 | 22 | int:SRPK2 |
| Interaction | SMC5 interactions | MYH9 PPIAL4D ARID4A RBBP6 CDK12 CFL1 RPS5 CFL2 HMGXB4 NOC3L ICE1 RBM28 THOC2 LDHA ADAR NKRF PPIAL4F BAZ1A PRRC2C RBM19 PPIAL4A BOD1L1 MPHOSPH10 TAF9 CTTN PPIAL4G | 7.61e-07 | 1000 | 178 | 26 | int:SMC5 |
| Interaction | KCNA3 interactions | MYH9 IL16 MYO6 RBBP6 CFL1 RPS5 ZDHHC5 DOCK10 YTHDC2 PFKM THOC2 LETM1 CLCC1 RYR1 LRPPRC PRRC2C OSBPL8 BOD1L1 EIF3G CTTN ADGRL2 CNN3 GOLGA4 | 2.73e-06 | 871 | 178 | 23 | int:KCNA3 |
| Interaction | PFN1 interactions | MYH9 TRIO CFL1 CFL2 SH3BGRL INPPL1 PCLO RTN3 MCM2 VIRMA HEXIM1 CEP350 SYNJ1 CHD5 NAV1 BOD1L1 GOLGA4 | 2.90e-06 | 509 | 178 | 17 | int:PFN1 |
| Interaction | H2BC4 interactions | MYH9 SHROOM3 MYO1H SAE1 MCM2 NEB VIRMA HEXIM1 CEP350 SCAF1 AKAP4 CHD5 | 3.45e-06 | 259 | 178 | 12 | int:H2BC4 |
| Interaction | CIT interactions | MYH9 KIF27 MYO6 RBBP6 CFL1 RPS5 CFL2 MYO1H PCLO NOC3L YTHDC2 RBM28 PFKM CMYA5 THOC2 ADAR VIRMA NKRF SCAF1 NLN LRPPRC LMO7 PRRC2C RBM19 HASPIN CNPY3 BOD1L1 MPHOSPH10 NUP188 GOLGA4 CCDC40 | 3.78e-06 | 1450 | 178 | 31 | int:CIT |
| Interaction | PIP5K1B interactions | 3.95e-06 | 13 | 178 | 4 | int:PIP5K1B | |
| Interaction | H2BC5 interactions | CYLC1 MYH9 NEBL PCLO MCM2 WDR76 VIRMA HEXIM1 CEP350 JARID2 SCAF1 CTTN MYBPC1 | 8.14e-06 | 331 | 178 | 13 | int:H2BC5 |
| Interaction | STX6 interactions | MIA3 MYO6 ZDHHC5 YTHDC1 CLCC1 CEMIP2 AP4E1 SLC12A2 SYNJ1 LNPEP OSBPL8 DNAJC5 ADGRL2 TRAPPC9 GOLGA4 | 1.11e-05 | 448 | 178 | 15 | int:STX6 |
| Interaction | NUP43 interactions | ARID4A RBBP6 CDK12 TPRKB NOC3L ICE1 CCDC168 SMARCAD1 RBM28 YTHDC1 VIRMA NKRF SCAF1 BAZ1A PRRC2C RBM19 BOD1L1 MPHOSPH10 | 1.13e-05 | 625 | 178 | 18 | int:NUP43 |
| Interaction | CDH1 interactions | MYH9 SHROOM3 NEBL MYO6 INPPL1 ZDHHC5 LDHA PIP5K1C CEMIP2 LRPPRC SLC12A2 SYNJ1 LMO7 FER ADAM17 CTTN ADGRL2 PCDH1 CNN3 TPD52 | 1.57e-05 | 768 | 178 | 20 | int:CDH1 |
| Interaction | NAA40 interactions | MYH9 NEBL MYO6 RBBP6 CDK12 CFL1 RANBP3 NOC3L MCM2 YTHDC2 ICE1 PFKM THOC2 LDHA ADAR NKRF SYNJ1 BAZ1A PRRC2C BOD1L1 EIF3G CTTN CNN3 | 1.79e-05 | 978 | 178 | 23 | int:NAA40 |
| Interaction | FGFBP1 interactions | CDK12 RPS5 NOC3L YTHDC2 RBM28 VIRMA NKRF SCAF1 BAZ1A RBM19 MPHOSPH10 | 1.87e-05 | 257 | 178 | 11 | int:FGFBP1 |
| Interaction | KIF20A interactions | TPM2 MYH9 SHROOM3 NEBL MYO6 RBBP6 CFL1 RPS5 CFL2 PCLO EML6 NOC3L HMGCR THOC2 TBC1D8B ADAR VIRMA NLN LRPPRC LMO7 RBM19 PIP5K1B BOD1L1 CTTN | 1.91e-05 | 1052 | 178 | 24 | int:KIF20A |
| Interaction | H3C4 interactions | 2.06e-05 | 19 | 178 | 4 | int:H3C4 | |
| Interaction | LYN interactions | MYH9 SDK2 TRIO MYO6 INPP5D INPPL1 ZDHHC5 RBM28 VIRMA CEMIP2 HEXIM1 SLC12A2 LNPEP HASPIN PIP5K1A IGSF9B ADGRL2 PPIAL4G PLXNA1 | 2.16e-05 | 720 | 178 | 19 | int:LYN |
| Interaction | STX7 interactions | SDK2 MIA3 MYO6 RAB11FIP2 ZDHHC5 CLCC1 CEMIP2 ARFGEF3 AP4E1 SLC12A2 SYNJ1 LNPEP OSBPL8 PIP5K1A DNAJC5 ADGRL2 HSD17B11 GOLGA4 | 2.29e-05 | 659 | 178 | 18 | int:STX7 |
| Interaction | PIP5KL1 interactions | 2.31e-05 | 7 | 178 | 3 | int:PIP5KL1 | |
| Interaction | MYPN interactions | 2.60e-05 | 40 | 178 | 5 | int:MYPN | |
| Interaction | H1-2 interactions | RPS5 INPPL1 NOC3L MCM2 GBP3 YTHDC2 NEB WDR76 FAM186B ZC3H3 VIRMA RGS7 HEXIM1 SCAF1 RBM19 XRRA1 BOD1L1 MPHOSPH10 | 2.63e-05 | 666 | 178 | 18 | int:H1-2 |
| Interaction | CAPZA2 interactions | TPM2 MYH9 MYO6 RBBP6 CFL1 CFL2 SH3BGRL MCM2 PFKM WDR76 VIRMA LRPPRC LMO7 CTTN | 2.98e-05 | 430 | 178 | 14 | int:CAPZA2 |
| Interaction | PURG interactions | 3.03e-05 | 223 | 178 | 10 | int:PURG | |
| Interaction | H2BC17 interactions | 3.51e-05 | 140 | 178 | 8 | int:H2BC17 | |
| Interaction | RAB7A interactions | CFL1 RTN3 VIRMA LETM1 CLCC1 CEMIP2 ARFGEF3 RMDN3 LRPPRC SLC12A2 TYW1B LNPEP OSBPL8 DNAJC5 TMEM131 ADAM17 ADGRL2 HSD17B11 PLXNA1 GOLGA4 TPD52 | 3.82e-05 | 886 | 178 | 21 | int:RAB7A |
| Interaction | PPIA interactions | TPM2 MYH9 NEBL TRIO CDK12 CFL1 SH3BGRL HMGXB4 MCM2 PFKM LDHA FAM186B ADAR VIRMA HEXIM1 NLN BAZ1A OSBPL8 MPHOSPH10 PPIAL4G GOLGA4 | 3.94e-05 | 888 | 178 | 21 | int:PPIA |
| Interaction | H2AC17 interactions | 4.24e-05 | 232 | 178 | 10 | int:H2AC17 | |
| Interaction | SIK2 interactions | 4.35e-05 | 106 | 178 | 7 | int:SIK2 | |
| Interaction | DSTN interactions | 4.41e-05 | 187 | 178 | 9 | int:DSTN | |
| Interaction | SYNPO interactions | 5.41e-05 | 192 | 178 | 9 | int:SYNPO | |
| Interaction | GJA1 interactions | SDK2 MIA3 TRIO MYO6 ZDHHC5 CLCC1 CEMIP2 AP4E1 SLC12A2 LNPEP OSBPL8 PIP5K1A DNAJC5 ADGRL2 HSD17B11 GOLGA4 | 6.29e-05 | 583 | 178 | 16 | int:GJA1 |
| Interaction | ARF6 interactions | MYO6 ZDHHC5 RBM28 PIP5K1C LETM1 CLCC1 CEMIP2 ARFGEF3 AP4E1 LRPPRC SLC12A2 LNPEP OSBPL8 PIP5K1A ADGRL2 PLXNA1 | 6.41e-05 | 584 | 178 | 16 | int:ARF6 |
| Interaction | EED interactions | MYH9 SHROOM3 TRIO MYO6 RBBP6 CFL1 RPS5 HMGXB4 NOC3L MCM2 SMARCAD1 RBM28 CHRAC1 THOC2 ADAR VIRMA NKRF JARID2 LRPPRC SYNJ1 BAZ1A RBM19 ADAM17 NUP188 EIF3G CTTN HSD17B11 CNN3 | 6.91e-05 | 1445 | 178 | 28 | int:EED |
| Interaction | LAMTOR1 interactions | MYO6 ZDHHC5 RBM28 PFKM CEMIP2 ARFGEF3 AP4E1 SLC12A2 SYNJ1 LNPEP OSBPL8 PIP5K1A DNAJC5 ZFYVE26 ADGRL2 TRAPPC9 GOLGA4 TPD52 | 7.47e-05 | 722 | 178 | 18 | int:LAMTOR1 |
| Interaction | KCTD13 interactions | MYH9 IL16 TRIO MYO6 CFL1 RPS5 CFL2 SPTA1 PCLO RTN3 NCAM2 YTHDC2 PFKM LDHA VIRMA LETM1 LRPPRC SYNJ1 LMO7 PRRC2C SORCS2 OSBPL8 NAV1 CTTN PCDH1 TRAPPC9 DNAH11 | 9.53e-05 | 1394 | 178 | 27 | int:KCTD13 |
| Interaction | ZC3H18 interactions | MYH9 SHROOM3 RBBP6 CDK12 CFL1 RPS5 NOC3L YTHDC2 SMARCAD1 RBM28 THOC2 LDHA YTHDC1 ADAR VIRMA NKRF PRRC2C PIP5K1A EIF3G NOVA2 | 1.00e-04 | 877 | 178 | 20 | int:ZC3H18 |
| Interaction | H2BC13 interactions | 1.08e-04 | 210 | 178 | 9 | int:H2BC13 | |
| Interaction | YWHAH interactions | SHROOM3 TRIO RANBP3 INPPL1 RAB11FIP2 MCM2 NCAM2 VIRMA CEP350 ARFGEF3 PARD6B RMDN3 SLC12A2 SYNJ1 LMO7 PRRC2C OSBPL8 NAV1 RASD1 DCLRE1A BOD1L1 TRAPPC9 GOLGA4 | 1.12e-04 | 1102 | 178 | 23 | int:YWHAH |
| Interaction | ADARB1 interactions | MYH9 CDK12 NOC3L YTHDC2 RBM28 THOC2 YTHDC1 ADAR NKRF SCAF1 LRPPRC RBM19 CHD5 MPHOSPH10 | 1.18e-04 | 489 | 178 | 14 | int:ADARB1 |
| Interaction | AP2B1 interactions | MYH9 MYO6 MCM2 PIP5K1C VIRMA HEXIM1 CEP350 CFAP54 SYNJ1 LNPEP NAV1 DNAJC5 | 1.25e-04 | 373 | 178 | 12 | int:AP2B1 |
| Interaction | SNAPIN interactions | 1.32e-04 | 169 | 178 | 8 | int:SNAPIN | |
| Interaction | ACTC1 interactions | MYH9 MYO6 RBBP6 CDK12 CFL1 RPS5 CFL2 MCM2 CHRAC1 VIRMA HEXIM1 SYNJ1 LMO7 CSTF1 BOD1L1 CTTN CNN3 | 1.47e-04 | 694 | 178 | 17 | int:ACTC1 |
| Interaction | TRIM37 interactions | TPM2 MYH9 KIF27 MYO6 RBBP6 CFL1 RPS5 LDHA VIRMA CEP350 HASPIN NAV1 RASD1 DCLRE1A ANKRD12 TMED10 | 1.54e-04 | 630 | 178 | 16 | int:TRIM37 |
| Interaction | LMAN1 interactions | MIA3 VIRMA CLCC1 CEMIP2 RMDN3 LRPPRC SLC12A2 LNPEP OSBPL8 CNPY3 DNAJC5 TMED10 HSD17B11 | 1.56e-04 | 441 | 178 | 13 | int:LMAN1 |
| Interaction | KRT8 interactions | SMG1 KRT26 MYH9 MIA3 ZDHHC5 WDR76 VIRMA HEXIM1 CEP350 NLN SYNJ1 NAV1 NUP188 | 1.56e-04 | 441 | 178 | 13 | int:KRT8 |
| Interaction | SRSF6 interactions | RBBP6 CDK12 RPS5 NOC3L YTHDC2 RBM28 YTHDC1 VIRMA NKRF HEXIM1 SCAF1 RBM19 PIP5K1A MPHOSPH10 | 1.58e-04 | 503 | 178 | 14 | int:SRSF6 |
| Interaction | CFL1 interactions | TPM2 CYLC1 MYH9 EFCAB6 CFL1 CFL2 SH3BGRL MCM2 LDHA VIRMA HEXIM1 CTTN | 1.64e-04 | 384 | 178 | 12 | int:CFL1 |
| Interaction | SYNE3 interactions | SHROOM3 MIA3 RTN3 TOGARAM1 CLCC1 CEP350 LMO7 OSBPL8 NAV1 CNPY3 TMEM131 TMED10 HSD17B11 | 1.66e-04 | 444 | 178 | 13 | int:SYNE3 |
| Interaction | H1-1 interactions | PPIAL4C RPS5 PCLO NOC3L MCM2 RBM28 CMYA5 ZC3H3 NKRF HEXIM1 FAIM LMO7 RBM19 MPHOSPH10 | 1.72e-04 | 507 | 178 | 14 | int:H1-1 |
| Interaction | HSPH1 interactions | MYH9 MYO6 CFL1 RANBP3 SH3BGRL MCM2 WDR76 VIRMA HEXIM1 PARD6B LRPPRC CNN3 GOLGA4 | 1.82e-04 | 448 | 178 | 13 | int:HSPH1 |
| Interaction | H1-6 interactions | 2.06e-04 | 229 | 178 | 9 | int:H1-6 | |
| Interaction | GJD3 interactions | MIA3 MYO6 ZDHHC5 RTN3 HMGCR CLCC1 CEMIP2 SLC12A2 LNPEP OSBPL8 TMEM131 ADGRL2 GOLGA4 | 2.07e-04 | 454 | 178 | 13 | int:GJD3 |
| Interaction | DUSP28 interactions | 2.19e-04 | 62 | 178 | 5 | int:DUSP28 | |
| Interaction | RSPH6A interactions | 2.22e-04 | 34 | 178 | 4 | int:RSPH6A | |
| Interaction | GLUD1P3 interactions | 2.31e-04 | 3 | 178 | 2 | int:GLUD1P3 | |
| Interaction | EEF1A1P5 interactions | 2.61e-04 | 141 | 178 | 7 | int:EEF1A1P5 | |
| Interaction | CAP2 interactions | 2.94e-04 | 66 | 178 | 5 | int:CAP2 | |
| Interaction | VASP interactions | SHROOM3 NEBL INPPL1 SPTA1 TEX9 VIRMA CEP350 ARFGEF3 SYNJ1 LMO7 | 2.96e-04 | 294 | 178 | 10 | int:VASP |
| Interaction | H2BC15 interactions | 2.96e-04 | 144 | 178 | 7 | int:H2BC15 | |
| Interaction | ACTBL2 interactions | MYH9 MYO6 CFL1 RPS5 SH3BGRL MCM2 WDR76 HEXIM1 OSBPL8 PPIAL4G | 3.12e-04 | 296 | 178 | 10 | int:ACTBL2 |
| Interaction | H2AB2 interactions | 3.77e-04 | 107 | 178 | 6 | int:H2AB2 | |
| Interaction | MYH9 interactions | TPM2 MYH9 SHROOM3 MYO6 CFL1 CFL2 MCM2 WDR76 VIRMA LETM1 HEXIM1 LRPPRC LMO7 PIP5K1A CTTN CNN3 GOLGA4 | 3.87e-04 | 754 | 178 | 17 | int:MYH9 |
| Interaction | BICD1 interactions | 3.94e-04 | 250 | 178 | 9 | int:BICD1 | |
| Interaction | CAPZB interactions | TPM2 MYH9 MYO6 RBBP6 CFL1 RPS5 CFL2 SH3BGRL MCM2 ADAR VIRMA HEXIM1 PARD6B LRPPRC LMO7 PRRC2C HASPIN OSBPL8 EIF3G CTTN CNN3 | 3.95e-04 | 1049 | 178 | 21 | int:CAPZB |
| Interaction | VCL interactions | 3.96e-04 | 305 | 178 | 10 | int:VCL | |
| Interaction | FGF8 interactions | 3.97e-04 | 108 | 178 | 6 | int:FGF8 | |
| Interaction | ANKRD50 interactions | 3.97e-04 | 108 | 178 | 6 | int:ANKRD50 | |
| Interaction | ARHGAP24 interactions | MYH9 CFL1 RPS5 DOCK10 MCM2 PFKM CMYA5 LDHA ADAR NKRF ZNF718 TLE4 CTTN | 3.97e-04 | 486 | 178 | 13 | int:ARHGAP24 |
| Interaction | NUDCD2 interactions | MYH9 CFL1 RPS5 SMARCAD1 LDHA YTHDC1 VIRMA LRPPRC SLC12A2 NEK8 PPIAL4A CTTN | 4.03e-04 | 424 | 178 | 12 | int:NUDCD2 |
| Cytoband | 1q21.2 | 1.89e-04 | 71 | 182 | 4 | 1q21.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | PPIAL4C PPIAL4D PPIAL4H ADAR PPIAL4F PPIAL4E PIP5K1A PPIAL4G | 2.27e-04 | 404 | 182 | 8 | chr1q21 |
| GeneFamily | Fibronectin type III domain containing | 4.36e-05 | 160 | 106 | 7 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 4.54e-05 | 161 | 106 | 7 | 593 | |
| GeneFamily | Myosin heavy chains | 8.47e-05 | 15 | 106 | 3 | 1098 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 6.91e-04 | 181 | 106 | 6 | 694 | |
| GeneFamily | Phosphoinositide phosphatases | 8.58e-04 | 32 | 106 | 3 | 1079 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.19e-03 | 9 | 106 | 2 | 1230 | |
| GeneFamily | EF-hand domain containing | 1.84e-03 | 219 | 106 | 6 | 863 | |
| GeneFamily | PHD finger proteins | 1.94e-03 | 90 | 106 | 4 | 88 | |
| GeneFamily | PDZ domain containing | 2.02e-03 | 152 | 106 | 5 | 1220 | |
| GeneFamily | AT-rich interaction domain containing | 3.40e-03 | 15 | 106 | 2 | 418 | |
| GeneFamily | WD repeat domain containing | 4.46e-03 | 262 | 106 | 6 | 362 | |
| GeneFamily | LIM domain containing | 5.02e-03 | 59 | 106 | 3 | 1218 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | SMG1 MIA3 RBBP6 CDK12 SH3BGRL MGAT4A TPRKB NOC3L SAE1 HMGCR RBM28 THOC2 ECHS1 RGS7 CEP350 RMDN3 LRPPRC NOD1 BAZ1A ENTPD1 OSBPL8 TMEM131 EIF3G TMED10 GOLGA4 TPD52 | 1.72e-07 | 1215 | 176 | 26 | M41122 |
| Coexpression | GSE40493_BCL6_KO_VS_WT_TREG_UP | SMG1 TRIO TPRKB ZDHHC5 SAE1 GUF1 GCLC BOD1L1 MPHOSPH10 GOLGA4 | 3.52e-07 | 177 | 176 | 10 | M9401 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | SHROOM3 PHF20 NEBL MYO6 ARID4A NBEAL1 RBBP6 ITGB8 CEMIP2 ARFGEF3 PARD6B AP4E1 JARID2 SLC12A2 LMO7 LNPEP TLE4 OSBPL8 UBR3 | 5.20e-06 | 854 | 176 | 19 | M1533 |
| Coexpression | DESCARTES_MAIN_FETAL_SKELETAL_MUSCLE_CELLS | 6.94e-06 | 194 | 176 | 9 | M40093 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | SHROOM3 PHF20 NEBL MYO6 ARID4A NBEAL1 RBBP6 ITGB8 CEMIP2 ARFGEF3 PARD6B AP4E1 JARID2 SLC12A2 LMO7 LNPEP TLE4 OSBPL8 UBR3 | 9.04e-06 | 888 | 176 | 19 | MM1018 |
| Coexpression | DESCARTES_FETAL_MUSCLE_SKELETAL_MUSCLE_CELLS | 9.39e-06 | 255 | 176 | 10 | M40254 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PHF20 TRIO ARID4A HMGXB4 TOGARAM1 THOC2 RGS7 CEP350 JARID2 LRPPRC BAZ1A PRRC2C TLE4 OSBPL8 PIP5K1A TMEM131 ADAM17 GOLGA4 | 1.98e-05 | 856 | 176 | 18 | M4500 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SMG1 MYH9 IL16 PHF20 ARID4A RBBP6 STK17B CFL1 INPP5D SH3BGRL MGAT4A DOCK10 GBP3 YTHDC2 ICE1 LDHA YTHDC1 ADAR CEP350 JARID2 BAZ1A LNPEP NBEAL2 OSBPL8 BOD1L1 | 2.28e-05 | 1492 | 176 | 25 | M40023 |
| Coexpression | DESCARTES_ORGANOGENESIS_MYOCYTES | 2.74e-05 | 129 | 176 | 7 | MM3644 | |
| Coexpression | GABRIELY_MIR21_TARGETS | ARID4A MGAT4A RAB11FIP2 DOCK10 YTHDC2 THOC2 ITGB8 CEMIP2 UBR3 GOLGA4 | 2.76e-05 | 289 | 176 | 10 | M2196 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | HMGXB4 TOGARAM1 ICE1 CEP350 JARID2 GCLC BAZ1A TLE4 MPHOSPH10 ADGRL2 | 3.78e-05 | 300 | 176 | 10 | M8702 |
| Coexpression | EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP | 6.50e-05 | 200 | 176 | 8 | M78 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | TRIO HMGXB4 RGS7 CEP350 JARID2 LRPPRC BAZ1A PRRC2C TLE4 OSBPL8 TMEM131 GOLGA4 | 7.86e-05 | 466 | 176 | 12 | M13522 |
| Coexpression | ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF | SHROOM3 STK17B NOC3L GBP3 SYBU ITGB8 PARD6B JARID2 GCLC PIP5K1A ADAM17 ANKRD12 CNN3 | 9.38e-05 | 550 | 176 | 13 | M2611 |
| Coexpression | NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_UP | IL16 PHF20 TRIO RBBP6 LETM1 CLCC1 CEMIP2 ENTPD1 PIP5K1A ANKRD12 TSTD2 TPD52 | 9.42e-05 | 475 | 176 | 12 | M40979 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | PHF20 EFCAB6 MYO6 ARID4A CDK12 EML6 TEX9 NKRF BAZ1A PRRC2C TMEM131 MPHOSPH10 TAF9 DSCC1 CCDC40 | 1.03e-05 | 469 | 178 | 15 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | kidney_adult_RenalCortexMixed_Std_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.03e-05 | 40 | 178 | 5 | gudmap_kidney_adult_RenalCortexMixed_Std_k4_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | SMG1 MYH9 PHF20 TRIO CDK12 MGAT4A HMGXB4 CEP350 BAZ1A LNPEP PRRC2C GOLGA4 | 3.06e-05 | 339 | 178 | 12 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000 | MYH9 SHROOM3 MYO1H PCLO RBM28 TEX9 WDR76 LDHA NKRF PARD6B JARID2 FAIM CDH20 GCLC BAZ1A NBEAL2 TLE4 HASPIN NAV1 MPHOSPH10 CCDC40 | 8.98e-05 | 991 | 178 | 21 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_1000 | 9.92e-05 | 127 | 178 | 7 | gudmap_developingGonad_e16.5_epididymis_1000_k4 | |
| CoexpressionAtlas | kidney_adult_Podocyte_MafB_top-relative-expression-ranked_500 | SHROOM3 NEBL MYO6 NBEAL1 MGAT4A TBC1D8B ITGB8 HEXIM1 PARD6B NOD1 SLC26A7 LNPEP OSBPL8 | 1.02e-04 | 445 | 178 | 13 | gudmap_kidney_adult_Podocyte_MafB_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | PHF20 CDK12 STK17B SAE1 NKRF LRPPRC SLC12A2 GCLC MPHOSPH10 NUP188 EIF3G | 1.22e-04 | 333 | 178 | 11 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000 |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 1.26e-04 | 31 | 178 | 4 | gudmap_kidney_P1_CapMes_Crym_k3_500 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#1_top-relative-expression-ranked_500 | 1.59e-04 | 61 | 178 | 5 | gudmap_kidney_P4_CapMesRenVes_Crym_k1_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | SHROOM3 PARD6B JARID2 OLFML2A CDH20 RBM19 NBEAL2 TLE4 CCDC40 | 1.76e-04 | 236 | 178 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K1 |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | MYO6 RBBP6 THOC2 CEP350 LMO7 BAZ1A PRRC2C OSBPL8 BOD1L1 ANKRD12 GOLGA4 | 6.64e-10 | 199 | 182 | 11 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | MYO6 ARID4A RBBP6 RBM28 THOC2 YTHDC1 CEP350 PRRC2C BOD1L1 ANKRD12 | 9.16e-09 | 197 | 182 | 10 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | RBBP6 TOGARAM1 TEX9 CEP350 BAZ1A PRRC2C OSBPL8 BOD1L1 ANKRD12 GOLGA4 | 1.01e-08 | 199 | 182 | 10 | 61b1ed2db71b96157b92b7535d1955a4033098da |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 1.01e-08 | 199 | 182 | 10 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | SHROOM3 PCLO GBP3 CEP350 LMO7 PRRC2C OSBPL8 BOD1L1 ANKRD12 GOLGA4 | 1.01e-08 | 199 | 182 | 10 | c425e7975f492ed5cfcca022248adb627e1d27d4 |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 1.01e-08 | 199 | 182 | 10 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-08 | 184 | 182 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-08 | 184 | 182 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-08 | 184 | 182 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | SMG1 ARID4A NBEAL1 RBBP6 CDK12 CEP350 BOD1L1 TMEM131 ANKRD12 | 7.76e-08 | 186 | 182 | 9 | 03db813598b67b1e08f759758a1c2023396921fa |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-07 | 195 | 182 | 9 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.27e-07 | 197 | 182 | 9 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.32e-07 | 198 | 182 | 9 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.32e-07 | 198 | 182 | 9 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 1.38e-07 | 199 | 182 | 9 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.44e-07 | 200 | 182 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.44e-07 | 200 | 182 | 9 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 8.99e-07 | 183 | 182 | 8 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-06 | 187 | 182 | 8 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.10e-06 | 188 | 182 | 8 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-06 | 188 | 182 | 8 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-06 | 190 | 182 | 8 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-06 | 193 | 182 | 8 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 1.34e-06 | 193 | 182 | 8 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-06 | 195 | 182 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 1.50e-06 | 196 | 182 | 8 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 1.68e-06 | 199 | 182 | 8 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 1.68e-06 | 199 | 182 | 8 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.68e-06 | 199 | 182 | 8 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.75e-06 | 200 | 182 | 8 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-OPC_related|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.75e-06 | 200 | 182 | 8 | ea1e3eeddbc398ac97863120f7aa3f17569ca12a | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.75e-06 | 200 | 182 | 8 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-OPC_related-Oligodendrocyte/OPC|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.75e-06 | 200 | 182 | 8 | 4a57f2f2dc6e2402ac4772b5cd38e033a6f1adee | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Mesoderm|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.75e-06 | 200 | 182 | 8 | 0f6851baf0cf2a8b0c95a7a585c4407c330c5f6c | |
| ToppCell | E12.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.08e-06 | 143 | 182 | 7 | cc396b81a5e47d78c2d1cb49d682391376b63476 | |
| ToppCell | P03-Hematopoietic-Erythroid|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.18e-06 | 144 | 182 | 7 | 2ee6a834860eac7ed004f366ab4fc38c4b80c905 | |
| ToppCell | P03-Hematopoietic-Erythroid-enucleate_erythrocyte|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.18e-06 | 144 | 182 | 7 | 9fa63904389f4d7163db22ea85ab721d8f6e8d99 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-cortical_neurons_1|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 4.02e-06 | 158 | 182 | 7 | 1f94622186d8329357fa06785e03eeacf29ab1ce | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition,_dividing_(more_DN)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.03e-06 | 168 | 182 | 7 | b9db0b1e4fe54a1fe79530d15d206155a1bfac39 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.09e-05 | 184 | 182 | 7 | 29c95b814a0b1ad8734ed68b77df29c08594e5ec | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.25e-05 | 188 | 182 | 7 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 1.25e-05 | 188 | 182 | 7 | 88b3415e33db81726dd29c1f50c886e057af50a0 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 1.25e-05 | 188 | 182 | 7 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | IPF-Epithelial-Club|IPF / Disease state, Lineage and Cell class | 1.30e-05 | 189 | 182 | 7 | f3fcef008ef252b29ac6d567fef27f9acf9cd70f | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.39e-05 | 191 | 182 | 7 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 191 | 182 | 7 | 9032aa974aa1b7b1095b8d1b58dcb087358a5001 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.39e-05 | 191 | 182 | 7 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 191 | 182 | 7 | 5717809a1476c20f65bce722c5a57cff92ee0d7a | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 1.44e-05 | 192 | 182 | 7 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-05 | 192 | 182 | 7 | f7e7491426bbd6ed29a465b58bf67acb93dbb90a | |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | 1.44e-05 | 192 | 182 | 7 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 1.44e-05 | 192 | 182 | 7 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.44e-05 | 192 | 182 | 7 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 1.44e-05 | 192 | 182 | 7 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-05 | 193 | 182 | 7 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | CF-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class | 1.49e-05 | 193 | 182 | 7 | 7ebf20344a9a154fd2cffa281526867fcf0aded3 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.54e-05 | 194 | 182 | 7 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.54e-05 | 194 | 182 | 7 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 1.54e-05 | 194 | 182 | 7 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon|organoid_Paulsen_bioRxiv / Sample Type, Dataset, Time_group, and Cell type. | 1.54e-05 | 194 | 182 | 7 | 4903a0d6e36599bcb83b179462e5b949df9eb685 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Pax6|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.59e-05 | 130 | 182 | 6 | 60e28d452d0e2af768459ba8dbe998117c94a251 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 1.59e-05 | 195 | 182 | 7 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | Control-Multiplet|Control / Disease state, Lineage and Cell class | 1.59e-05 | 195 | 182 | 7 | 618900c80bea09d46dad3f741bd1bff8bf0a64ee | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-05 | 195 | 182 | 7 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 1.59e-05 | 195 | 182 | 7 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | Control-Multiplet-Multiplet|Control / Disease state, Lineage and Cell class | 1.59e-05 | 195 | 182 | 7 | 06ac685855e14e4dd2cbe6d0e73f894f2eeff91f | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.59e-05 | 195 | 182 | 7 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | CV-Moderate-6|Moderate / Virus stimulation, Condition and Cluster | 1.59e-05 | 195 | 182 | 7 | 2b8a72d7e755b9655c7a496000d10ff06e50862b | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.64e-05 | 196 | 182 | 7 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.64e-05 | 196 | 182 | 7 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 1.64e-05 | 196 | 182 | 7 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-05 | 196 | 182 | 7 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | moderate-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.64e-05 | 196 | 182 | 7 | 9152f4a8a27ff4ee28f231c5ad00eb2edd9ea6da | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 1.64e-05 | 196 | 182 | 7 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | COVID-19-Heart-Mito_CM|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.70e-05 | 197 | 182 | 7 | 44e49943d62bfe622b40ad0460093d31540544df | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.70e-05 | 197 | 182 | 7 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.75e-05 | 198 | 182 | 7 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | metastatic_Brain-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 1.75e-05 | 198 | 182 | 7 | 86a4c8e859ce11a95875f8844963baeb1ba898ec | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.75e-05 | 198 | 182 | 7 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.75e-05 | 198 | 182 | 7 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | medial|World / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.75e-05 | 198 | 182 | 7 | 071658de0c43f302172692aa0b4b507dbad7be50 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.81e-05 | 133 | 182 | 6 | 5bf5e654653e2c340891f51e3f2a30441b7b6b2b | |
| ToppCell | cellseq2-Epithelial|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.81e-05 | 199 | 182 | 7 | 2d4fb558845764f937efaf39962caaeb2c85478b | |
| ToppCell | normal_Lung-Endothelial_cells-Tip-like_ECs|Endothelial_cells / Location, Cell class and cell subclass | 1.81e-05 | 199 | 182 | 7 | 72c96a5954dfcfbfee8f095984ce1f5249d9a679 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 1.81e-05 | 199 | 182 | 7 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | NS-critical-LOC-Epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.81e-05 | 199 | 182 | 7 | d64adb68502be596ce55fb2cb63fe1cfa2c5f8ba | |
| ToppCell | (07)_Ionocytes|World / shred by cell type by condition | 1.81e-05 | 199 | 182 | 7 | 8194777d367405a7840787e977854b5c07e3bd6b | |
| ToppCell | NS-critical-d_07-13-Epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.81e-05 | 199 | 182 | 7 | b88a81cd2a89f4d27100c96ae4324dcee68daf83 | |
| ToppCell | control-Epithelial|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.87e-05 | 200 | 182 | 7 | f95bbb94e51ac28b1995026c599ec3a34e012916 | |
| ToppCell | NS-control-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.87e-05 | 200 | 182 | 7 | d014959891893b6d3854a471fba1dc50c6625a0a | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 1.87e-05 | 200 | 182 | 7 | ad2a6da0b1ae7a9212a3c91e5eec4baa7481d8dc | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.87e-05 | 200 | 182 | 7 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.87e-05 | 200 | 182 | 7 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.87e-05 | 200 | 182 | 7 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 1.87e-05 | 200 | 182 | 7 | 0350e5ffd36033099b7e32a1fdd790fff99790dc | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Mesenchymal-Mesoderm|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.87e-05 | 200 | 182 | 7 | 538ae964db58c4acafe93f735b3e03fc08fdaac6 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.87e-05 | 200 | 182 | 7 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 1.87e-05 | 200 | 182 | 7 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.87e-05 | 200 | 182 | 7 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.87e-05 | 200 | 182 | 7 | 13ec8afea86e4a10599c924871ba4e325b0a8013 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.15e-04 | 49 | 106 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED | |
| Computational | Genes in the cancer module 201. | 1.26e-04 | 50 | 106 | 5 | MODULE_201 | |
| Computational | Genes in the cancer module 202. | 1.52e-04 | 28 | 106 | 4 | MODULE_202 | |
| Drug | AC1N9ZZC | 2.55e-07 | 149 | 176 | 10 | CID004369374 | |
| Drug | blebbistatin | 3.40e-06 | 116 | 176 | 8 | CID003476986 | |
| Disease | Distal arthrogryposis | 1.37e-07 | 9 | 172 | 4 | cv:C0265213 | |
| Disease | Multiple pterygium syndrome | 7.75e-07 | 4 | 172 | 3 | C0265261 | |
| Disease | Digitotalar Dysmorphism | 3.84e-06 | 6 | 172 | 3 | C1852085 | |
| Disease | ARTHROGRYPOSIS, DISTAL, TYPE 1 | 3.84e-06 | 6 | 172 | 3 | C0220662 | |
| Disease | Nemaline myopathy | 1.07e-05 | 8 | 172 | 3 | cv:C0206157 | |
| Disease | Distal arthrogryposis syndrome | 3.38e-05 | 2 | 172 | 2 | C0265213 | |
| Disease | Digitotalar dysmorphism; ulnar drift, hereditary | 3.38e-05 | 2 | 172 | 2 | cv:C1852085 | |
| Disease | LETHAL CONGENITAL CONTRACTURAL SYNDROME 3 | 3.38e-05 | 2 | 172 | 2 | C1969655 | |
| Disease | Congenital myopathy (disorder) | 4.12e-05 | 12 | 172 | 3 | C0270960 | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 8.41e-05 | 15 | 172 | 3 | DOID:0050646 (implicated_via_orthology) | |
| Disease | interleukin 10 measurement | 9.50e-05 | 78 | 172 | 5 | EFO_0004750 | |
| Disease | MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE | 4.99e-04 | 6 | 172 | 2 | C1854678 | |
| Disease | procollagen C-endopeptidase enhancer 1 measurement | 4.99e-04 | 6 | 172 | 2 | EFO_0801920 | |
| Disease | Congenital myopathy with fiber type disproportion | 4.99e-04 | 6 | 172 | 2 | cv:C0546264 | |
| Disease | ARTHROGRYPOSIS, DISTAL, TYPE 2B | 4.99e-04 | 6 | 172 | 2 | C1834523 | |
| Disease | creatinine measurement, glomerular filtration rate | 6.28e-04 | 117 | 172 | 5 | EFO_0004518, EFO_0005208 | |
| Disease | Nemaline Myopathy, Childhood Onset | 6.96e-04 | 7 | 172 | 2 | C0546125 | |
| Disease | Myopathies, Nemaline | 9.24e-04 | 8 | 172 | 2 | C0206157 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.47e-03 | 10 | 172 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.47e-03 | 10 | 172 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.47e-03 | 10 | 172 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.47e-03 | 10 | 172 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | level of Phosphatidylcholine (O-18:2_16:0) in blood serum | 1.47e-03 | 10 | 172 | 2 | OBA_2045132 | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.47e-03 | 10 | 172 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.47e-03 | 10 | 172 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.47e-03 | 10 | 172 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.47e-03 | 10 | 172 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | coronary artery disease | SHROOM3 MIA3 TTC41P ARID4A NBEAL1 CDK12 INPP5D HMGCR AP4E1 CEP120 LNPEP FER MPHOSPH10 C5 TMED10 ADGRL2 | 1.73e-03 | 1194 | 172 | 16 | EFO_0001645 |
| Disease | neuroticism measurement, cognitive function measurement | 1.87e-03 | 566 | 172 | 10 | EFO_0007660, EFO_0008354 | |
| Disease | APOE carrier status, cerebral amyloid angiopathy | 1.89e-03 | 42 | 172 | 3 | EFO_0006790, EFO_0007659 | |
| Disease | distal myopathy (implicated_via_orthology) | 2.15e-03 | 12 | 172 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 2.15e-03 | 12 | 172 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | Mammary Neoplasms, Experimental | 2.20e-03 | 155 | 172 | 5 | C0024668 | |
| Disease | Autosomal Dominant Myotubular Myopathy | 2.53e-03 | 13 | 172 | 2 | C3661489 | |
| Disease | Centronuclear myopathy | 2.53e-03 | 13 | 172 | 2 | C0175709 | |
| Disease | X-linked centronuclear myopathy | 2.53e-03 | 13 | 172 | 2 | C0410203 | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 2.53e-03 | 13 | 172 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | Myopathy, Centronuclear, 1 | 2.53e-03 | 13 | 172 | 2 | C4551952 | |
| Disease | Congenital Structural Myopathy | 2.53e-03 | 13 | 172 | 2 | C0752282 | |
| Disease | myopathy (implicated_via_orthology) | 2.78e-03 | 48 | 172 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | Myopathy, Centronuclear, Autosomal Dominant | 2.94e-03 | 14 | 172 | 2 | C1834558 | |
| Disease | Tubular Aggregate Myopathy | 2.94e-03 | 14 | 172 | 2 | C0410207 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 3.37e-03 | 105 | 172 | 4 | DOID:9352 (implicated_via_orthology) | |
| Disease | Autosomal Recessive Centronuclear Myopathy | 3.37e-03 | 15 | 172 | 2 | C3645536 | |
| Disease | phosphatidylethanolamine measurement | 3.52e-03 | 173 | 172 | 5 | EFO_0010228 | |
| Disease | reticulocyte measurement | TPM2 MYH9 INPP5D SPTA1 EML6 PFKM NOD1 CDH20 SLC12A2 BAZ1A NEK8 DNAJC5 TMEM131 MYBPC1 | 3.58e-03 | 1053 | 172 | 14 | EFO_0010700 |
| Disease | waist circumference | 3.81e-03 | 429 | 172 | 8 | EFO_0004342 | |
| Disease | Ciliopathies | 3.98e-03 | 110 | 172 | 4 | C4277690 | |
| Disease | HOMA-B | 4.09e-03 | 55 | 172 | 3 | EFO_0004469 | |
| Disease | fatty acid measurement | 4.20e-03 | 436 | 172 | 8 | EFO_0005110 | |
| Disease | Glycogen storage disease | 4.34e-03 | 17 | 172 | 2 | cv:C0017919 | |
| Disease | FEV change measurement, response to bronchodilator | 4.75e-03 | 58 | 172 | 3 | EFO_0005921, GO_0097366 | |
| Disease | Congenital Fiber Type Disproportion | 4.86e-03 | 18 | 172 | 2 | C0546264 | |
| Disease | disease free survival | 4.86e-03 | 18 | 172 | 2 | EFO_0000409 | |
| Disease | cortical surface area measurement | EFCAB5 SHROOM3 FBXL13 NBEAL1 STK17B DOCK10 HMGCR SMARCAD1 SYBU ITGB8 CEP120 PRRC2C TLE4 NAV1 ADGRL2 DNAH11 | 5.52e-03 | 1345 | 172 | 16 | EFO_0010736 |
| Disease | creatinine measurement | SHROOM3 CDK12 TPRKB NEB RGS7 RYR1 AP4E1 CDH20 PRRC2C PIP5K1A PIP5K1B ADGRL2 MUSK | 5.71e-03 | 995 | 172 | 13 | EFO_0004518 |
| Disease | venous thromboembolism | 5.76e-03 | 460 | 172 | 8 | EFO_0004286 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TLKTKLLVSDKSYDG | 181 | Q6P461 | |
| KDDGSSFYNLTKLKD | 2246 | Q96N23 | |
| YGKAQVAKSSSKESR | 161 | Q9NYV4 | |
| SRIYLAKDKTTGQSK | 266 | O75821 | |
| IYASSKDAIKKKLTG | 116 | P23528 | |
| GKTQKIYEASIKSTE | 586 | P29374 | |
| ETTFAKILKEKGYAT | 126 | P51690 | |
| SESEGSDYSPNKKKK | 86 | Q8TDI0 | |
| FLYSELSNKSKSGDK | 301 | Q5JQC9 | |
| SSSGKAEYSVKIELK | 431 | Q96KE9 | |
| GEKFSESLKKYKSTS | 46 | A0A1B0GVH6 | |
| LTADVTKKTKEDYGH | 4406 | Q96DT5 | |
| KKVKSEGTDSYVSQL | 1341 | O95490 | |
| KERKPSTTSSGKYED | 251 | P32238 | |
| KTEVASSSYAIEKKT | 856 | Q8IYM0 | |
| NDSTYDKVGKTHIKA | 1136 | O95622 | |
| KQSDNSEYSKSEKGK | 936 | Q6UB98 | |
| YSSAKKVKAEIGDVS | 101 | Q8NBQ5 | |
| SATKKFSYKLVKTGS | 151 | Q8N5I2 | |
| DGVIKIKASSLSTYK | 236 | Q9NRL2 | |
| YSNTLHDTGDKELKK | 831 | Q9UPM8 | |
| YSSTEEKTTLKDKNA | 2556 | Q6ZS30 | |
| KESLAESAAAYTKAT | 366 | Q9H6Z4 | |
| EDASALGSSSYKKKK | 486 | Q9Y4C8 | |
| AKDKYKDTQSVSAIG | 191 | Q9NW13 | |
| YIREKASAGSQAKDK | 261 | Q9Y272 | |
| IETSAKTGYNVKKLF | 171 | Q5JT25 | |
| SKGDKIVSAHTQKTY | 281 | Q8N442 | |
| YSAFGTDTLIKKKNV | 101 | Q9BYG5 | |
| LDGEERKSKSTCYKS | 391 | Q7Z3Y9 | |
| KIVSGKDYNVTANSK | 76 | P00338 | |
| GTAKSQFLKYIEKVS | 526 | P49736 | |
| SSLSGKIQKLTDKDY | 366 | Q9UM21 | |
| GYRNSKTSKKITIAD | 146 | A0A0B4J2A2 | |
| AKASGELASNIKYKE | 571 | Q86VF7 | |
| YKKGTESHLSELNTK | 1666 | Q13439 | |
| SKGTEKALSKLHEYF | 661 | P04035 | |
| SKTGEEKYVEESKAS | 591 | O95202 | |
| IYASSKDAIKKKFTG | 116 | Q9Y281 | |
| KTGLYSKRAAAKSDD | 221 | O94992 | |
| TLTEGSKLEKKLFYS | 251 | P30084 | |
| TGNDAKSVSKQYSLK | 746 | Q86VH2 | |
| KESYVKSTIQSKEGG | 46 | P13535 | |
| IADKYSAESSQKKTS | 1676 | Q9Y6V0 | |
| YLKSKETGKKFASVD | 641 | Q9UIW2 | |
| SETGSDSKKKYFLQT | 446 | Q08174 | |
| KDTYASLGKTNVKDD | 56 | Q02045 | |
| KAGKITDEEATKSSY | 141 | P08237 | |
| NEEKTYKKTASSAIK | 16 | O14986 | |
| YKKTASSAIKGAIQL | 21 | O14986 | |
| KDTKKYPESTDTESG | 361 | P35663 | |
| SAFRKVKYSGSKTDS | 621 | P48506 | |
| GTPKVYKSADSSTVK | 766 | Q14005 | |
| SKILSSKSKAYTVVG | 151 | Q86SG6 | |
| GKYLALAVKNSKSIS | 801 | Q9Y239 | |
| TSKSSCYLEEEKAKT | 376 | Q8WWI1 | |
| KSSVDQAGKYSKTVA | 601 | O00566 | |
| SKYQSVSLLDKKSGV | 666 | Q9UIQ6 | |
| KSYVSEKDVTSAKAL | 1326 | P42704 | |
| EYSLKLTQGTSQKDK | 201 | Q9H0R5 | |
| LAYVASSHKSKKDQG | 191 | P35579 | |
| DSELYFLGTDTHKKK | 61 | Q9UGU5 | |
| GYRNSKTSKKITIAD | 146 | P0DN26 | |
| GLDKNATSDDIKKSY | 21 | Q9H3Z4 | |
| EIKTSYAGVKEKYLS | 396 | P49961 | |
| ETGATIKLSKSKDFY | 61 | Q9UNW9 | |
| TYKKTTSSALKGAIQ | 76 | Q99755 | |
| GYRNSKTSKKITIAD | 146 | A0A075B759 | |
| ASSEKGKTKDRDYSV | 1396 | Q7Z6E9 | |
| GYRNSKTSKKITIAD | 146 | F5H284 | |
| GYRNSKTSKKITIAD | 146 | A0A075B767 | |
| KSESKLYNGSEKDSS | 96 | Q9BZF1 | |
| IKSSSDYRVSASKKD | 716 | P26012 | |
| GYRNSKTSKKITIAD | 146 | Q9Y536 | |
| GYRNSKTSKKITIAD | 146 | P0DN37 | |
| LAKEKYKSDKDSTST | 996 | Q8NFC6 | |
| SQSRKDSILKSTKYG | 671 | A4FU69 | |
| ISSDSYGSIDKRKVK | 191 | Q9Y2F5 | |
| SKDKTYDLKIADTSN | 76 | Q9BVC3 | |
| NAKKKEALETSVGYA | 776 | Q96BY6 | |
| IYDSKRQSGKTKETS | 1111 | P55265 | |
| SKSYEKVEKALSAGD | 296 | Q5THR3 | |
| KQYQDSTEIASGKKD | 916 | Q8N960 | |
| EVYKGTLKDKTSVAV | 576 | P16591 | |
| LSFESKKSYTLKVEG | 341 | Q9HBT6 | |
| EASGSKYKAIKESCT | 11 | Q5TH69 | |
| DQKASGVKYTKSDLR | 81 | Q9BT09 | |
| IKAKYKEDFSTTGTA | 201 | P01031 | |
| TGIYDKARKKKTTSN | 186 | Q8N3K9 | |
| QAKSTDGEIEAYKKS | 526 | Q4G0X9 | |
| YSKLKGKEECASVSS | 31 | Q86WZ0 | |
| KETFYVGAAKTKATI | 51 | Q9NVQ4 | |
| KEGTLDSKHQKYSAS | 1511 | Q5VT06 | |
| YKSKATITLYGKSDE | 196 | Q9UHN6 | |
| KGALELTVKKSTYSS | 716 | Q8NEE6 | |
| SISNKKASDAEKVYG | 451 | Q8TF76 | |
| KGDLSDSSKYKISSS | 66 | Q86VF2 | |
| SDIKFSKDTGKYLAV | 1086 | Q6ZMW3 | |
| ILKSVEKATDGKYQS | 31 | Q6PJP8 | |
| LKIQDSSDSGKKAYT | 4976 | Q8NDH2 | |
| KNSKYILSSGKDSVA | 316 | Q05048 | |
| QSKKYAKKTDSGNSA | 1956 | Q58EX2 | |
| DASYSSKAEKKATVD | 2716 | P21817 | |
| KKGQTYAAEDKTSVD | 156 | Q8NE79 | |
| IESSDYDSSSSKGKK | 116 | Q9UNL4 | |
| KDISKYGSVQKSFAD | 231 | Q68BL7 | |
| TVTKGAVTYTKAKRE | 341 | Q92833 | |
| KSNVVSLKAYKGLAE | 326 | Q8WTT2 | |
| KVTAVNKDGTYTVKF | 106 | Q9BVI0 | |
| SLKTYSQEKRGKALS | 221 | Q8NH83 | |
| SIKKGPKSASSYSDI | 1226 | Q8NEY1 | |
| SEIKDIGSKYSEQSK | 701 | O95197 | |
| AKGSSNSYAIKKKDE | 181 | P46782 | |
| LDDAKIYSSHAKKAT | 51 | Q16594 | |
| KKKGSRSKSTEFYSE | 5026 | O75445 | |
| SSAYQELLQAKKKSG | 441 | P49802 | |
| TEEVSEKKSYALDGK | 291 | Q96TC7 | |
| SSKTKSADEQSIYEK | 691 | Q9H4L7 | |
| LSSAEKEAIKGTYSK | 41 | O43426 | |
| EKGKDTLKSAYDDTE | 511 | Q5JRA6 | |
| YGTKKTSKHAAADEA | 391 | O15226 | |
| YEAAGEAVKTLKKTQ | 501 | O15226 | |
| YKKTTSSTLKGAIQL | 71 | O60331 | |
| RSGEVISSKEKSKYK | 156 | Q6ZNJ1 | |
| TYKALETVGEKKAFS | 256 | Q96Q15 | |
| YTKESKLYVSSDLGK | 266 | Q96PQ0 | |
| AKDGKKYATLSLFNT | 11 | Q9Y520 | |
| YIASSSGSTAIKKKQ | 6 | O75368 | |
| ISKSTGQEYAAKFLK | 51 | O94768 | |
| IIKKSKDGSEDKFYS | 326 | Q92835 | |
| KKGLSKTSDQAYIEF | 736 | O15357 | |
| SSRKEAVSLVKGSYK | 86 | Q8TF72 | |
| KELNKYASLKAVGSS | 271 | B4DS77 | |
| SEKAKAALKRTTSDY | 226 | Q9UBE0 | |
| VDSKEEYAKGKIKSS | 41 | P11055 | |
| TFDLKKTLSYIGVSK | 316 | Q8IW75 | |
| STKNYGKTILTKEAD | 386 | P78536 | |
| GKEKKVLTYSDLANT | 66 | Q9NRG0 | |
| KSQAKYGISGEKDVS | 41 | Q96S66 | |
| GLSAEVKNKIASKYD | 11 | Q15417 | |
| KSVTLYTVKDKATGE | 416 | Q9BYT8 | |
| KSDSVLLTSGKYDLK | 1376 | A0JNW5 | |
| SNSNKDKIRYTGDKT | 156 | Q3SXZ3 | |
| GVLYKVSANKLSKTS | 606 | Q8IXZ2 | |
| ISSKYDELKKSEKGS | 826 | Q8NI27 | |
| SSGKSKELEEGKAAY | 746 | O15394 | |
| YTEVKSKDASKGDEL | 911 | Q0IIM8 | |
| SKEDATKGKFAFTTE | 86 | P49755 | |
| SVDDKYIVTGSGDKK | 751 | Q04727 | |
| AISSKKYSVAKAEAE | 826 | Q9UPX0 | |
| DKSAVGHEYQSKLSK | 96 | Q14247 | |
| IQSSRYKKESKSGLV | 126 | Q9NX95 | |
| SSSEGRGDTDKYLKK | 1196 | Q9H7N4 | |
| STKEYVNNTKEKFGL | 256 | Q8N4C7 | |
| GTKDVVVSVEYSKKS | 946 | P55011 | |
| ITLKASESKYTKVAS | 376 | Q92545 | |
| SGKEASKKKTDYSSN | 1211 | Q6P2S7 | |
| SKKKTDYSSNILSLG | 1216 | Q6P2S7 | |
| SGKSTAKKVYSFLDK | 456 | Q5SRE5 | |
| SLKAELDGSTKKKYS | 36 | Q5T7W7 | |
| SINKSGASYEKIKEV | 301 | Q9BWV7 | |
| QLGKEKYSTSVAEKT | 41 | Q7L804 | |
| ATSTYLGKDLIASKK | 816 | P02549 | |
| NKRIVSTKGKSATEY | 81 | Q96MU7 | |
| ESYAGSEKKHEKLSS | 321 | Q96MU7 | |
| KDEVQLKTTYSKSNG | 661 | Q9C0B5 | |
| ANRYLTVKKKDGSET | 96 | Q9H6S0 | |
| SKNTEKGLSSIKSYK | 281 | Q9H967 | |
| GALKKSTCDAEKSYE | 1591 | Q6ZT12 | |
| KKKSEYVGATNSAFE | 191 | Q8TAG6 | |
| VTSKVLTTKEKLYGD | 751 | Q96Q05 | |
| ITEYKQGKTDVAKTL | 1096 | Q6PGP7 | |
| EKDAKVSISKSTYNK | 1166 | Q9Y4F4 | |
| YKKTSETLSQAGQKA | 136 | P55327 | |
| LAQGSAKKFKYSIDD | 326 | Q8TE54 | |
| SLEAQADKYSTKEDK | 206 | P07951 | |
| YYSKEALGDSKSKKS | 831 | Q69YN4 | |
| SHKAKSYTELGEKLS | 2276 | Q68DK2 | |
| GRKTNSSVKLKYSDV | 126 | Q8N6V9 | |
| SLKATSFEFKGKKES | 61 | Q6P2D8 | |
| YVSVDASTKDSLKKI | 466 | Q6NUM6 | |
| EVKDSSGRSKYLYKS | 1521 | O75962 | |
| KKIYKLSSQEESIGT | 146 | Q9Y3C4 | |
| KQKIEYSALKGVSTS | 926 | Q8N1T3 | |
| VAKNSLGTAYSKVVK | 191 | O15146 | |
| AVLATKAAAGTKKYD | 1071 | Q9UM54 | |
| AAITGYTIQKADKKS | 961 | Q00872 | |
| EAKYKGTIKADLSNS | 86 | O76041 | |
| SLEVEKAKKATEYAS | 2186 | P20929 |